BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11221869)

  • 1. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
    Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
    Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Tcf4 residues involved in high-affinity beta-catenin binding.
    Omer CA; Miller PJ; Diehl RE; Kral AM
    Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
    Chen RH; McCormick F
    Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
    Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
    J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC truncation and increased beta-catenin levels in a human breast cancer cell line.
    Schlosshauer PW; Brown SA; Eisinger K; Yan Q; Guglielminetti ER; Parsons R; Ellenson LH; Kitajewski J
    Carcinogenesis; 2000 Jul; 21(7):1453-6. PubMed ID: 10874025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M; Nakamura Y; Obama K; Furukawa Y
    Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
    Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
    Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
    Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
    Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
    Mariadason JM; Bordonaro M; Aslam F; Shi L; Kuraguchi M; Velcich A; Augenlicht LH
    Cancer Res; 2001 Apr; 61(8):3465-71. PubMed ID: 11309309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjö A; Söderkvist P
    Anticancer Res; 2001; 21(2A):911-5. PubMed ID: 11396184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.
    Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenomatous polyposis coli protein (APC)-independent regulation of beta-catenin/Tcf-4 mediated transcription in intestinal cells.
    Baulida J; Batlle E; García De Herreros A
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):565-70. PubMed ID: 10567241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients.
    Inomata M; Ochiai A; Akimoto S; Kitano S; Hirohashi S
    Cancer Res; 1996 May; 56(9):2213-7. PubMed ID: 8616874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.